Trial intelligence / Profile preview

Upper gastrointestinal handling of branded versus generic alendronate tablets

2005-003924-21Phase 4Completed

Sponsor
University of Nottingham
Start
Oct 2005
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, single-blind trial of alendronate in osteoporosis (2 arms), sponsored by University of Nottingham. Primary endpoints: Oesophageal transit time and Incidences of tablet sticking. Started Oct 2005; status: completed.

02

Drugs

alendronate
03

Conditions

osteoporosis

Beyond the preview

Go deeper on 2005-003924-21.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-003924-21.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call